Prognostic Evaluation Using Nutrition-Inflammation Biomarkers from Routine Blood Tests in Metastatic Breast Cancer: A Boruta Algorithm-Optimized Feature Selection Study - Poll - MDSpire

Prognostic Evaluation Using Nutrition-Inflammation Biomarkers from Routine Blood Tests in Metastatic Breast Cancer: A Boruta Algorithm-Optimized Feature Selection Study

  • By

  • Nong, Wen-xiong

  • Huang, Sheng-kai

  • Zhang, Wenhai

  • Tan, Yang

  • Wu, Zhi-dong

  • Liang, Wan-wang

  • Wu, Rui-zheng

  • May 13, 2026

  • 0 min

Share

Original Source(s)

Prognostic Evaluation Using Nutrition-Inflammation Biomarkers from Routine Blood Tests in Metastatic Breast Cancer: A Boruta Algorithm-Optimized Feature Selection Study

  • by Nong, Wen-xiong , Huang, Sheng-kai , Zhang, Wenhai , Tan, Yang , Wu, Zhi-dong , Liang, Wan-wang , Wu, Rui-zheng

  • May 13, 2026

Related Content

High-grade astrocytoma with piloid features: a case report of comprehensive management

A patient with triple-negative breast cancer developed acute myocardial infarction after docetaxel chemotherapy: case report and literature review

Percutaneous nephrostomy as a marker of clinical vulnerability in non-metastatic muscle-invasive bladder cancer: prognostic and infectious implications